Long-term follow-up study of necrotising pancreatitis: interventions, complications and quality of life
Robbert A Hollemans,Hester C Timmerhuis,Marc G Besselink,Stefan A W Bouwense,Marco Bruno,Peter van Duijvendijk,Erwin-Jan van Geenen,Muhammed Hadithi,Sybrand Hofker,Jeanin E Van-Hooft,Liesbeth M Kager,Eric R Manusama,Jan-Werner Poley,Rutger Quispel,Tessa Römkens,George P van der Schelling,Matthijs P Schwartz,Bernhard W M Spanier,Martijn Stommel,Adriaan Tan,Niels G Venneman,Frank Vleggaar,Roy L J van Wanrooij,Thomas L Bollen,Rogier P Voermans,Robert C Verdonk,Hjalmar C van Santvoort
DOI: https://doi.org/10.1136/gutjnl-2023-329735
IF: 24.5
2024-01-24
Gut
Abstract:Objective To describe the long-term consequences of necrotising pancreatitis, including complications, the need for interventions and the quality of life. Design Long-term follow-up of a prospective multicentre cohort of 373 necrotising pancreatitis patients (2005–2008) was performed. Patients were prospectively evaluated and received questionnaires. Readmissions (ie, for recurrent or chronic pancreatitis), interventions, pancreatic insufficiency and quality of life were compared between initial treatment groups: conservative, endoscopic/percutaneous drainage alone and necrosectomy. Associations of patient and disease characteristics during index admission with outcomes during follow-up were assessed. Results During a median follow-up of 13.5 years (range 12–15.5 years), 97/373 patients (26%) were readmitted for recurrent pancreatitis. Endoscopic or percutaneous drainage was performed in 47/373 patients (13%), of whom 21/47 patients (45%) were initially treated conservatively. Pancreatic necrosectomy or pancreatic surgery was performed in 31/373 patients (8%), without differences between treatment groups. Endocrine insufficiency (126/373 patients; 34%) and exocrine insufficiency (90/373 patients; 38%), developed less often following conservative treatment (p 50% during initial admission was associated with percutaneous/endoscopic drainage (OR 4.3 (95% CI 1.5 to 12.2)), pancreatic surgery (OR 3.2 (95% CI 1.1 to 9.5) and development of endocrine insufficiency (OR13.1 (95% CI 5.3 to 32.0) and exocrine insufficiency (OR6.1 (95% CI 2.4 to 15.5) during follow-up. Conclusion Acute necrotising pancreatitis carries a substantial disease burden during long-term follow-up in terms of recurrent disease, the necessity for interventions and development of pancreatic insufficiency, even when treated conservatively during the index admission. Extensive (>50%) pancreatic parenchymal necrosis seems to be an important predictor of interventions and complications during follow-up.
gastroenterology & hepatology